1. |
Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI, et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study[J]. Hormones (Athens), 2010, 9(4):312-317.
|
2. |
Lee JH, Kim Y, Choi JW, et al. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis:a meta-analysis[J]. Eur J Endocrinol, 2013, 168(3):343-349.
|
3. |
Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland[J]. AMA Arch Surg, 1955, 70(2):291-297.
|
4. |
Konturek A, Barczynski M, Wierzchowski W, et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis[J]. Langenbecks Arch Surg, 2013, 398(3):389-394.
|
5. |
Jeong JS, Kim HK, Lee CR, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma:clinical manifestation and prognostic outcome[J]. J Korean Med Sci, 2012, 27(8):883-889.
|
6. |
Okayasu I, Fujiwara M, Hara Y, et al. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans[J]. Cancer, 1995, 76(11):2312-2318.
|
7. |
Zhang Y, Dai J, Wu T, et al. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma[J]. J Cancer Res Clin Oncol. 2014, 140(6):1021-1026.
|
8. |
Meier A, Sclafa R, Rosen D, et al. Expression of RET/PTC fusion gene as a marker for papillary carcinoma in Hashimotos thyroiditis[J]. Laryngoscope, 1997, 107(1):95-100.
|
9. |
Nikiforov YE. RET/PTC rearrangement in thyroid tumors[J]. Endocr Pathol, 2002, 13(1):3-16.
|
10. |
Rhoden KJ, Unger K, Salvatore G, et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes:follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma[J]. J Clin Endocrinol Metab, 2006, 91(6):2414-2423.
|
11. |
Kang DY, Kim KH, Kim JM, et al. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population[J]. Thyroid, 2007, 17(11):1031-1038.
|
12. |
李晓梅, 侯刚. CK19、COX-2、hTERT在桥本甲状腺炎合并甲状腺乳头状癌中的表达及意义[J].临床与实验病理学杂志, 2010, 26(5):619-622.
|
13. |
Burstein DE, Nagi C, Wang BY, et al. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis:a stem cell hypothesis of papillary carcinoma oncogenesis[J]. Hum Pathol, 2004, 35(4):465-473.
|
14. |
Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway[J]. J Am Coll Surg, 2007, 204(5):764-773; discussion 773-775.
|
15. |
Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies:prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma[J]. J Clin Endocrinol Metab, 1998, 83(4):1121-1127.
|
16. |
Guarino V, Castellone MD, Avilla EA. Thyroid cancer and inflammation[J]. Mol Cell Endocrinol, 2010, 321(1, SI):94-102.
|
17. |
Fiore E, Rago T, Latrofa F, et al. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma:role of TSH and of treatment with L-thyroxine[J]. Endocr Relat Cancer, 2011, 18(4):429-437.
|
18. |
Franco AT, Malaguarnera R, Refetoff S, et al. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice[J]. Proc Natl Acad Sci USA, 2011, 108(4):1615-1620.
|
19. |
Duntas LH. Environmental factors and autoimmune thyroiditis[J]. Nat Clin Pract Endocrinol Metab, 2008, 4(8):454-460.
|
20. |
Kasagi K. Epidemiology of thyroid tumors:effect of environmental iodine intake[J]. Nihon Rinsho, 2007, 65(11):1953-1958.
|
21. |
Williams ED. Chernobyl and thyroid cancer[J]. J Surg Oncol, 2006, 94(8):670-677.
|
22. |
Tronko MD, Brenner AV, Olijnyk VA, et al. Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident:results from the first screening cycle (1998-2000)[J]. J Clin Endocrinol Metab, 2006, 91(11):4344-4351.
|
23. |
Vykhovanets EV, Chernyshov VP, Slukvin II, et al. 131I dose-dependent thyroid autoimmune disorders in children living around Chernobyl[J]. Clin Immunol Immunopathol, 1997, 84(3):251-259.
|
24. |
Kurukahvecioglu O, Taneri F, Yüksel O, et al. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma[J]. Adv Ther, 2007, 24(3):510-516.
|
25. |
Schäffler A, Palitzsch KD, Seiffarth C, et al. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma[J]. Eur J Clin Invest, 1998, 28(10):838-844.
|
26. |
Cunha LL, Morari EC, guihen AC, et al. Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer[J]. Endocr Relat Cancer, 2012, 19(3):131-l36.
|
27. |
Kwon JH, Nam ES, Shin HS, et al. P2X7 receptor expression in coexistence of papillary thyroid carcinoma with hashimoto's thyroiditis[J]. Korean J Pathol, 2014, 48(1):30-35.
|
28. |
Del Rio P, Cataldo S, Sommaruga L, et al. The association between papillary carcinoma and chronic lymphocytic thyroiditis:does it modify the prognosis of cancer?[J]. Minerva Endocrinol, 2008, 33(1):1-5.
|